In a recent investigation, Wu et al. demonstrated that DAPA exhibits efficacy in reducing HFrEF stemming from both myocardial infarction (MI) and transverse aortic constriction (TAC) and showed that SGLT2 global knockout mice could not be protected from heart failure. The gene discussed is SLC5A2; the disease is heart failure.